Sri Ambikare Pharma Private Limited

Sri Ambikare Pharma Private Limited - pharma in Mahbubnagar, Telangana, India. FY 2026 financials & compliance.
CIN U24232TG2007PTC056228 Incorporated 06 November 2007 ROC Hyderabad HQ Mahbubnagar, Telangana, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2024
₹90.96 Lakh
▲ 189% YoY
Net loss · FY 2024
₹2.74 Lakh
Net margin -3%
EBITDA · FY 2024
-₹1.27 Lakh
EBITDA margin -1.4%
Authorised capital
₹16 Cr
Registered with MCA
Paid-up capital
₹3 Cr
Issued & subscribed
Satisfied charges
₹21.5 Cr
No open charges
Company age
19 yrs
Est. 2007
Directors on board
2
As per MCA filings

About Sri Ambikare Pharma Private Limited

Data last updated:

Sri Ambikare Pharma Private Limited is a private limited company based in Mahbubnagar, Telangana, India, a subsidiary of Psn Medicare Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 November 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2007PTC056228. Its GSTIN is 36AABCL3774C2ZN (Telangana). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹16 Cr and a paid-up capital of ₹3 Cr. It was formerly known as Leesa Lifesciences Private Limited. It is led by directors Kasthur Reddy Nemallapudi and Ramadevi Nemallapudi.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at P2 Sy.No.423(P) 424(P) And 425(P) Jedcherla Mandal Polepally, Mahbubnagar, Telangana, India – 509203.

As per the financials filed for FY 2024, the company reported a revenue of ₹90.96 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹2.74 Lakh (net margin -3%) and EBITDA of -₹1.27 Lakh (EBITDA margin -1.4%).

As per MCA filings, the company has satisfied charges of ₹21.5 Cr on record. Court records list 27 cases involving the company, including 5 filed by the company and 22 filed against it; 4 cases are pending.

Sri Ambikare Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-18-0005918). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website leesalifesciences.com.

Company details

CIN U24232TG2007PTC056228
Registration Number 056228
Incorporation Date 06 November 2007
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Parent Company Psn Medicare Private Limited
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-18-0005918

CIN history

Sri Ambikare Pharma has one previous CIN (Corporate Identification Number): U24232AP2007PTC056228. The current CIN is U24232TG2007PTC056228, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232TG2007PTC056228Current
U24232AP2007PTC056228Previous

Recognitions & Rankings of Sri Ambikare Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-TS-18-0005918

Contact details

Sri Ambikare Pharma Private Limited's registered office is in Mahbubnagar, Telangana. Its website is leesalifesciences.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    P2 Sy.No.423(P) 424(P) And 425(P) Jedcherla Mandal Polepally, Mahbubnagar, Telangana, India – 509203
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Sri Ambikare Pharma Private Limited, buy the company report.

Comprehensive company report
Sri Ambikare Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Sri Ambikare Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Sri Ambikare Pharma Private Limited, buy the company report.

Financials of Sri Ambikare Pharma Private Limited

FY 2024 filings available

Sri Ambikare Pharma Private Limited reported revenue of ₹90.96 Lakh (up 189% YoY) for FY 2024.

Revenue · FY 2024
₹90.96 Lakh ▲ 189%
Net loss · FY 2024
₹2.74 Lakh margin -3%
EBITDA · FY 2024
-₹1.27 Lakh margin -1.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 189%

Revenue rose 189% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations₹90.96 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹1.27 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹2.74 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-1.4%
Net Profit Margin-3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sri Ambikare Pharma Private Limited, buy the company report.

Board of directors of Sri Ambikare Pharma Private Limited

Sri Ambikare Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kasthur Reddy NemallapudiDirector18 Oct 20224 Years 0 MonthsCurrent
Ramadevi NemallapudiDirector18 Oct 20224 Years 0 MonthsCurrent

Auditor

Sri Ambikare Pharma Private Limited is audited by A.S.R.V. Prasad & Co for the financial year 2024.

Auditor firmFinancial yearFirm registration number
A.S.R.V. Prasad & CoFY 2024009983S

Shareholding

The shareholding of Sri Ambikare Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sri Ambikare Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹21.5 Cr
Breakdown by lending institutions
State Bank of India₹21.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
08 Dec 200910188705State Bank of India₹21.5 CrSatisfied

To see the full charge records of Sri Ambikare Pharma Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sri Ambikare Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Sri Ambikare Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
36AABCL3774C2ZNTelanganaActive01 Mar 2023

To see the full GST registrations and return filing status of Sri Ambikare Pharma Private Limited, buy the company report.

Recent activity

Sri Ambikare Pharma Private Limited has 7 board changes on record since 2008: 2 appointments and 5 cessations. The latest: Kasthur Reddy Nemallapudi was appointed as Director on 18 Oct 2022.

AGM
Sri Ambikare Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Sri Ambikare Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge registered on 08 Dec 2009 via Charge ID 10188705 with State Bank Of India was fully satisfied on 06 Jan 2023.
Appointed
Kasthur Reddy Nemallapudi was appointed as Director.
Appointed
Ramadevi Nemallapudi was appointed as Director.
Ceased
Venkata Varaprasad Rao Gupta Kothuri ceased to be Director.
Ceased
Naveen Kumar Naraharisetty ceased to be Additional Director.
Charges
A charge with State Bank Of India of Rs. 21.50 Cr registered on 08 Dec 2009 with Charge ID 10188705 was modified on 28 Sep 2011.
Ceased
Grandhi Venkata Rao ceased to be Director.
Ceased
Nagendra Prasad K ceased to be Director.
Charges
A charge with State Bank Of India amounted to Rs. 21.50 Cr with Charge ID 10188705 was registered on 08 Dec 2009.
Ceased
Koteswara Rao Kolla ceased to be Director.

1 earlier event is in the company report.

Frequently asked questions

Sri Ambikare Pharma is an active private limited company based in Mahbubnagar, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 November 2007 (19+ years old) and is registered under CIN U24232TG2007PTC056228.

Sri Ambikare Pharma has 2 current directors:

The latest financial statements of Sri Ambikare Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Sri Ambikare Pharma is 36AABCL3774C2ZN, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of Sri Ambikare Pharma is U24232TG2007PTC056228. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sri Ambikare Pharma has 27 court cases on record: 5 filed by the company and 22 filed against it. 4 are pending. Most are in the nclat.

Sri Ambikare Pharma was incorporated on 06 November 2007, making it 19+ years old. It is registered with the Registrar of Companies, Hyderabad.

Kasthur Reddy Nemallapudi was appointed as Director on 18 Oct 2022. Ramadevi Nemallapudi was appointed as Director on 18 Oct 2022. Venkata Varaprasad Rao Gupta Kothuri ceased to be Director on 18 Oct 2022. Sri Ambikare Pharma has 7 board changes on record in total.

Yes, Sri Ambikare Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-18-0005918).

Sri Ambikare Pharma can be reached through the website leesalifesciences.com. Its registered office is in Mahbubnagar, Telangana, India.